Abstract
Rationale Two proposed hypotheses for irritable bowel syndrome (IBS) are acute gastroenteritis and bacterial overgrowth. We studied whether acute infection with Campylobacter could precipitate bacterial overgrowth in a rat model in order to link the two hypotheses. Methods Sprague-Dawley outbred rats were randomly administered a vehicle or Campylobacter jejuni strain 81-176 by oral gavage. Three months after clearance of the infectious agent, rats had a stool consistency evaluation. After euthanasia, lumenal bacteria counts were measured via quantitative real-time PCR from self-contained segments of the duodenum, jejunum, ileum, cecum and left colon. Adjacent sections of bowel were fixed in formalin for evaluation of intraepithelial lymphocyte counts. Results Three months after clearance of Campylobacter infection, 57% of Campylobacter infected rats had some alteration in stool consistency compared to 7.4% in mock-infected controls (P < 0.001). Among the rats that received Campylobacter, 27% had evidence of bacterial overgrowth by PCR. These rats also had the highest prevalence of altered stool form and had lower body weight. Consistent with post-infectious IBS in humans, bacterial overgrowth rats demonstrated a significant increase in rectal and left colon intraepithelial lymphocytes. Conclusions Acute infection with C. jejuni 81-176 precipitates alterations in stool consistency, bacterial overgrowth and rectal lymphocytosis consistent with findings in IBS patients.
Similar content being viewed by others
References
Neal KR, Hebden J, Spiller R (1997) Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis, and risk factors for development of the irritable bowel syndrome: postal survey of patients. Br Med J 314:779–782
Parry SD, Stansfield R, Jelley D, Gregory W, Phillips E, Barton JR, Welfare MR (2003) Is irritable bowel syndrome more common in patients presenting with bacterial gastroenteritis? A community-based, case-control study. Am J Gastroenterol 98:238–241
Barber R, Blakey A (1997) Prevalence of gastrointestinal symptoms after bacterial gastroenteritis: study did not include control group. Br Med J 314:1903
Neal KR, Barker L, Spiller RC (2002) Prognosis in post-infectious irritable bowel syndrome: a six-year follow up study. Gut 51:410–413
Okhuysen PC, Jiang ZD, Carlin L et al. (2004) Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterology 99:1774–1778
Mearin F, Perez-Oliveras M, Perello A et al. (2005) Dyspepsia and irritable bowel syndrome after a Salmonella outbreak: one-year follow-up cohort study. Gastroenterology 129:98–104
Spiller RC, Jenkins D, Thornley JP et al. (2000) Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 47:804–811
Dunlop SP, Jenkins D, Neal KR, Spiller RC (2003) Relative importance of enterochromaffin cell hyperplasia, anxiety and depression in post-infectious IBS. Gastroenterology 125:1651–1659
Zaidel O, Park S, van den Burg B, Kong Y, Lechago J, Stein T, Morgan M, Pimentel M (2004) Intraepithelial lymphocytes and enteroendocrine cells are not increased in general IBS subjects compared to controls. Neurogastroenterol Mot
Pimentel M, Chow EJ, Lin HC (2000) Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastro 95:3503–3506
Pimentel M, Chow EJ, Lin HC (2003) Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo controlled study. Am J Gastroenterol 98:412–419
Lupascu A, Gabrielli M, Lauritano EC et al. (2005) Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther 22:1157–1160
Posserud I, Stotzer P-O, Bjornsson ES et al. (2007) Altered counts of small bowel bacteria in patients with irritable bowel syndrome (IBS). Gut 56:802–808
Sharara AI, Aoun E, Abdul-Baki H et al (2006) A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol 101:326–333
Pimentel M, Park S, Mirocha J, Kane S, Kong Y (2006) The effect of a nonabsorbed oral antibiotic (Rifaximin) on the symptoms of the irritable bowel syndrome. A randomized trial. Ann Intern Med 145:557–563
Bercik P, Wang L, Verdu EF et al (2004) Visceral hyperalgesia and intestinal dysmotility in a mouse model of post-infective gut dysfunction. Gastroenterology 127:179–187
Vantrappen G, Janssens J, Hellemans J, Ghoos Y (1977) The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest 59:1158–1166
Pimentel M, Soffer EE, Chow EJ, Lin HC (2002) Lower frequency of MMC is found in IBS subjects with abnormal breath test suggesting bacterial overgrowth. Dig Dis Sci 47:2639–2643
Nadkarni MA, Martin FE, Jacques NA, Hunter N (2002) Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 148:257–266
King TS, Toskes PP (1979) Small intestinal bacterial overgrowth. Gastroenterol 76:1035–1055
Szurszewski JH (1969) A migrating electrical complex of canine small intestine. Am J Physiol 217:1757–1763
Neal KR, Hebden J, Spiller R (1997) Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. Br Med J 314:779–782
Mish B, Ilyas AA, Koski CL et al. (1993) Serologic evidence of previous Campylobacter jejuni infection in patients with Guillain-Barré Syndrome. Ann Intern Med 118:947–953
Rees JH, Soudain SE, Gregson NA, Hughes RAC (1995) Campylobacter jejuni infection and Guillain-Barré Syndrome. N Engl J Med 18:137–164
Acknowledgements
We would like to thank the Shoolman Foundation for their support of this study. We would also like to thank the Beatrice and Samuel A. Seaver Foundation for their support of the histologic portions of this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pimentel, M., Chatterjee, S., Chang, C. et al. A New Rat Model Links Two Contemporary Theories in Irritable Bowel Syndrome. Dig Dis Sci 53, 982–989 (2008). https://doi.org/10.1007/s10620-007-9977-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-007-9977-z